What technical signals does GRI BIO (GRI) have?

GRI BIO current technical signals: no active technical signal.

Is GRI BIO a cup-and-handle pattern?

No. GRI BIO has no valid Cup signal right now.

What published figures are available for GRI BIO?

Market cap: $0.4M. Trailing 12 months PER: -0.4×. Latest quarter PBR: 0.34×. Dividend yield: 0.00%.

← Signal Board

GRI BIO stock price

GRI 바이오NASDAQ:GRI · Nasdaq · Healthcare

$1.91-2.55%

2026-10-05 close · prelim

Today's signals · No active technical signal.

Signal details →

GRI BIO last closed at $1.91 (-2.55%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is -0.4×. Its overall grade ranks 301 of 739 stocks in Healthcare.

About this company

GRI BIO last closed at $1.91 (-2.55%) on 2026-10-05. Listed on Nasdaq.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall B · 301/739

Valuation grade B

Details →

Related stocks

Gilead SciencesCompetitor
RNA/세포치료 기반 항암·면역질환 치료제 개발에서 경쟁
Vertex PharmaceuticalsCompetitor
희귀질환·세포/유전자치료 분야에서 유사한 혁신 신약 개발 경쟁
Beam TherapeuticsCompetitor
유전자 편집 기반 치료제 개발 경쟁사

Details →

About GRI BIO

What technical signals does GRI BIO (GRI) have?: GRI BIO current technical signals: no active technical signal.
Is GRI BIO a cup-and-handle pattern?: No. GRI BIO has no valid Cup signal right now.
What published figures are available for GRI BIO?: Market cap: $0.4M. Trailing 12 months PER: -0.4×. Latest quarter PBR: 0.34×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Turn what you saw on this name into a strategy

Ask Q about GRI BIO, or open the plan table on the main site.

Ask Q ↗See plans ↗

From the names you found to a trading rule

Tell Q about the stocks you found to place orders with your conditions.

See plans ↗

Quantus Signal · live data · not investment advice · Privacy Policy